Evidence map›Paper›PMID 34009314›Full record

ArticleRheumatology (Oxford, England)2021

The effect of COVID-19 public health restrictions on the health of people with musculoskeletal conditions and symptoms: the CONTAIN study.

Gary J Macfarlane, Rosemary J Hollick, LaKrista Morton, Maureen Heddle, Eva-Maria Bachmair, R Stuart Anderson, Daniel Whibley, Karen Forrest Keenan, Peter Murchie, Kevin Stelfox and 2 more

Abstract read
In one paragraph

Article in Rheumatology (Oxford, England), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Musculoskeletal and Neuropathic Pain in COVID-19.Diagnostics (Basel, Switzerland) · 2024
    Review
  6. Review
  7. Article
  8. Review
  9. Observational
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Gary J MacfarlaneEpidemiology Group and Aberdeen Centre for Arthritis and Musculoskeletal Health, Aberdeen, UK.ORCID 0000-0003-2322-3314
Rosemary J HollickEpidemiology Group and Aberdeen Centre for Arthritis and Musculoskeletal Health, Aberdeen, UK.ORCID 0000-0001-6558-7189
LaKrista MortonEpidemiology Group and Aberdeen Centre for Arthritis and Musculoskeletal Health, Aberdeen, UK.
Maureen HeddleEpidemiology Group and Aberdeen Centre for Arthritis and Musculoskeletal Health, Aberdeen, UK.
Eva-Maria BachmairEpidemiology Group and Aberdeen Centre for Arthritis and Musculoskeletal Health, Aberdeen, UK.
R Stuart AndersonEpidemiology Group and Aberdeen Centre for Arthritis and Musculoskeletal Health, Aberdeen, UK.
Daniel WhibleyEpidemiology Group and Aberdeen Centre for Arthritis and Musculoskeletal Health, Aberdeen, UK.
Karen Forrest KeenanEpidemiology Group and Aberdeen Centre for Arthritis and Musculoskeletal Health, Aberdeen, UK.
Peter MurchieCentre for Primary Care Research, School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, UK.
Kevin StelfoxEpidemiology Group and Aberdeen Centre for Arthritis and Musculoskeletal Health, Aberdeen, UK.
Marcus J BeasleyEpidemiology Group and Aberdeen Centre for Arthritis and Musculoskeletal Health, Aberdeen, UK.
Gareth T JonesEpidemiology Group and Aberdeen Centre for Arthritis and Musculoskeletal Health, Aberdeen, UK.ORCID 0000-0003-0016-7591

Funding

Versus Arthritis 20748Versus Arthritis Foundation Fellowship 21742
6 · The paper itself

Abstract

objectiveTo quantify the change in quality of life, disease-specific indicators, health and lifestyle before and during the COVID-19 pandemic among people with musculoskeletal diagnoses and symptoms.

methodsWe undertook an additional follow-up of two existing UK registers involving people with axial spondyloarthritis (axSpA) or psoriatic arthritis (PsA) and participants in a trial in the UK who had regional pain and were identified at high risk of developing chronic widespread pain. Participants completed the study questionnaire between July and December 2020, throughout which time there were public health restrictions in place.

resultsThe number of people taking part in the study was 1054 (596 axSpA, 162 PsA, 296 regional pain). In comparison with their previous (pre-pandemic) assessment, there was an age-adjusted significant, small decrease in quality of life measured by EQ-5D [-0.020 (95% CI -0.030, -0.009)] overall and across all population groups examined. This was primarily related to poorer mental health and pain. There was a small increase in fibromyalgia symptoms, but a small decrease in sleep problems. There was a small deterioration in axSpA disease activity, and disease-specific quality of life and anxiety in PsA participants. Predictors of poor quality of life were similar pre- and during the pandemic. The effect of lockdown on activity differed according to age, gender and deprivation.

conclusionImportant lessons include focusing on addressing anxiety and providing enhanced support for self-management in the absence of normal health care being available, and awareness that all population groups are likely to be affected.

Indexed as

Communicable Disease ControlCOVID-19Quality of LifeAdultAgedAnxietyChronic PainFemaleFollow-Up StudiesHealth Services AccessibilityHumansMaleMiddle AgedMusculoskeletal DiseasesPatient Acceptance of Health CareRegistriesaxial spondyloarthritisCOVID-19painpsoriatic arthritisquality of life

Identifiers

PMID34009314
PMCPMC8244573

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.